NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

生物相容性材料的全球市場分析:隨著對醫療器械和生物製藥需求的增長,促進增長

Global Market Study on Biocompatible Materials: Rising Demand for Medical Devices & Biopharmaceutical Products Catalyzing Growth

出版商 Persistence Market Research 商品編碼 991837
出版日期 內容資訊 英文 255 Pages
商品交期: 2-3個工作天內
價格
生物相容性材料的全球市場分析:隨著對醫療器械和生物製藥需求的增長,促進增長 Global Market Study on Biocompatible Materials: Rising Demand for Medical Devices & Biopharmaceutical Products Catalyzing Growth
出版日期: 2020年12月21日內容資訊: 英文 255 Pages
簡介

本報告分析了生物相容性材料的全球市場,並提供了產品,市場結構,主要市場促進/限制因素,市場規模/份額趨勢和預測(2020-2030年)的概述。物料類型/用途/最終用戶和地區/主要國家/地區,當前市場競爭狀況,主要公司的概況等

目錄

第1章執行摘要

第2章市場概述

第3章主要市場趨勢

  • 主要製造趨勢
  • 製造/發展趨勢
  • 主要產品功能

第4章主要成功因素

  • 主要規定
  • 產品滲透率分析
  • 醫療器械供應鏈分析
  • 物料類型/應用矩陣

第5章市場背景

  • 宏觀經濟因素
    • 全球GDP增長展望
    • 全球醫療支出前景
  • 預測因素:相關性和影響
    • 操作次數增加
    • 激活研究活動
    • 生物相容性材料的製造成本
    • 生物相容性植入物的普及
    • 醫療費用和可支配收入增加
  • 市場動態
    • 市場推廣因素
    • 市場約束因素
    • 市場機會分析
  • 預測因素:相關性和影響

第6章冠狀病毒感染(COVID-19)危機分析

  • COVID-19:當前的統計數據和未來的預期影響
  • 當前GDP預測和預期影響
  • 截至2008年的經濟分析:與當前經濟預測的比較
  • COVID-19和影響分析:按國家
  • 2020年的市場前景
  • 恢復方案:短期,中期,長期影響

第7章全球生物相容性材料市場:需求分析/預測

  • 過去市場規模分析
  • 當前和未來市場規模的預測
    • 同比增長率趨勢分析(YoY)

第8章全球生物相容性材料市場分析和預測:按材料類型

  • 簡介/主要發現
  • 過去市場規模分析:按物料類型(基於價值)
  • 當前和未來市場規模的分析和預測:按物料類型(價值基礎)
    • 聚合物
    • 金屬
    • 陶瓷
    • 複合材料
  • 市場向心力分析:按材料類型

第9章:全球生物相容性材料市場分析和預測:通過應用

  • 簡介/主要發現
  • 過去市場規模分析:按應用(價值基準)
  • 當前和未來市場規模的分析和預測:按應用(基於價值)
    • 手術器械/醫療器械
    • 植入物
    • 藥物輸送(藥物輸送)
    • 其他
  • 市場向心力分析:按應用

第10章對全球生物相容性材料市場的分析和預測:最終用戶

  • 簡介/主要發現
  • 過去市場規模分析:按最終用戶(基於價值)
  • 當前和未來市場規模的分析和預測:按最終用戶(基於價值)
    • 醫療器械製造商
    • 教育研究所
    • 生物製藥/製藥公司
  • 市場向心力分析:按最終用戶劃分

第11章:全球生物相容性材料市場分析和預測:按地區

  • 簡介/主要發現
  • 過去市場規模分析:按地區(基於價值)
  • 當前和未來市場規模的分析和預測:按地區(基於價值)
    • 北美
    • 拉丁美洲
    • 歐洲
    • 東亞
    • 南亞
    • 大洋洲
    • 中東/非洲(MEA)

第12章北美生物相容性材料市場的分析和預測

  • 簡介/主要發現
  • 過去市場規模分析:按市場類別
  • 當前和未來市場規模的分析和預測:按市場類別
    • 按國家
    • 按材料類型
    • 按應用
    • 最終用戶
  • 市場向心力分析
  • 主要的市場進入公司:競爭密度圖

第13章對拉丁美洲生物相容性材料市場的分析和預測

第14章對歐洲生物相容性材料市場的分析和預測

第15章南亞生物相容性材料市場分析和預測

第16章東亞生物相容性材料市場的分析和預測

第17章大洋洲生物相容性材料市場的分析和預測

第18章中東和非洲的生物相容性材料市場分析和預測

第19章主要/新興國家生物相容性材料市場的分析和預測

  • 美國市場分析
    • 按材料類型
    • 按應用
    • 最終用戶
  • 加拿大市場分析
  • 巴西市場分析
  • 阿根廷市場分析
  • 墨西哥市場分析
  • 英國市場分析
  • 德國市場分析
  • 法國市場分析
  • 意大利市場分析
  • 西班牙市場分析
  • 俄羅斯市場分析
  • 印度市場分析
  • 馬來西亞市場分析
  • 泰國市場分析
  • 印尼市場分析
  • 中國市場分析
  • 日本市場分析
  • 韓國市場分析
  • 澳大利亞市場分析
  • 新西蘭市場分析
  • 海灣合作委員會(GCC)國家市場分析
  • 南非市場分析

第20章市場結構分析

  • 市場分析:按公司層次劃分
  • 市場集中度
  • 主要公司的市場份額分析
  • 市場佔有率分析
    • 按地區/公司
    • 按渠道/公司

第21章競爭分析

  • 競爭性儀表板
  • 公司之間的比較分析
  • 比賽詳情
    • Dupont
    • Ensinger
    • Stratasys Ltd.
    • Covestro AG
    • Foster Corporation
    • Merck KGaA
    • BASF SE (Exxon Mobil Corporation)
    • Wacker Chemie AG
    • Celanese Corporation
    • Royal DSM
    • Evonik Industries AG
    • Shin-Etsu Chemical Co. Ltd.
    • Henkel AG & Co.

第22章先決條件,縮寫詞列表

第23章分析方法

目錄
Product Code: PMRREP32234

Scope of the Report:

A latest publication by Persistence Market Research (PMR) on the global biocompatible materials market evaluates the opportunities and current market landscape, and provides detailed analysis and updates about corresponding sections affecting the global biocompatible materials market. The study offers detailed insights on key market dynamics, which includes the drivers, restraints, trends, and opportunities in the biocompatible materials market. The principal aim of the market study is to present exclusive information about how the market will perform over the forecast period of 2020-2030.

Important indicators for the successful growth of the biocompatible materials market are presented in this comprehensive report, which include Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described in an exhaustive way in PMR's research. This research study can support readers to know the demand for biocompatible materials and quantitative development opportunities during the study period.

The research is beneficial for shareholders in the biocompatible materials market, including market investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the biocompatible materials market. Insights and wisdom presented in this PMR study can be leveraged by shareholders in the biocompatible materials market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.

Market statistics as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the biocompatible materials market are also included in the current study. Depending on potential developments in the biocompatible materials market, substantive insights are also encountered in this report. Additionally, by virtue of the data submitted in this market report, minor companies and new entrants in the biocompatible materials industry can be aided in making suitable company choices to achieve traction in the biocompatible materials market.

Key Questions Answered:

  • Which regions will continue to remain the most profitable regional markets for biocompatible materials market players?
  • Which factors will induce a change in the demand for biocompatible materials during the assessment period?
  • How will changing trends impact the biocompatible materials market?
  • How can market players capture the low-hanging opportunities in the biocompatible materials market in developed regions?
  • What are the winning strategies of stakeholders in the biocompatible materials market to upscale their position in this landscape?
  • What are the restraints that investors need to be aware of and might tackle while investing in the biocompatible materials market?
  • What are the developmental trends in biocompatible material sectors that will impact the market?
  • How can businesses in the biocompatible materials market avail the growth opportunities in developed and emerging sectors?

Research Methodology:

In PMR's study, a unique research methodology is utilized to conduct extensive research on the growth of the biocompatible materials market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the biocompatible materials market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the biocompatible materials market, and makes PMR's projections on the growth prospects of the biocompatible materials market more accurate and reliable.

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusion and Exclusions

3. Key Market Trends

  • 3.1. Key Manufacturing Trends
  • 3.2. Manufacturing and Development Trends
  • 3.3. Key Product features

4. Key Success Factors

  • 4.1. Key Regulations
  • 4.2. Product Adoption analysis
  • 4.3. Medical Device Supply Chain Analysis
  • 4.4. Material Type-Application matrix

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP outlook
    • 5.1.2. Global Healthcare Outlook
    • 5.1.3. Global Healthcare Expenditure Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Increasing number of surgeries
    • 5.2.2. Increasing number of research activities
    • 5.2.3. Cost of manufacturing Biocompatible materials
    • 5.2.4. Adoption of biocompatible implants
    • 5.2.5. Increasing Healthcare Expenditure & Disposable Income
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID19 Crisis Analysis

  • 6.1. Current COVID19 Statistics and Probable Future Impact
  • 6.2. Current GDP Projection and Probable Impact
  • 6.3. Current Economic Projection as compared to 2008 Economic analysis
  • 6.4. COVID19 and Impact Analysis, by Country
  • 6.5. 2020 Market Scenario
  • 6.6. Recovery Scenario - Short term, Midterm and Long Term Impact

7. Global Biocompatible Materials Market Demand Value (US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2015-2019
  • 7.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Biocompatible Materials Market Analysis 2015-2019 and Forecast 2020-2030, by Material Type

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Biocompatible Materials Market (US$ Mn) By Material Type, 2015-2019
  • 8.3. Current and Future Biocompatible Materials Market (US$ Mn) Analysis and Forecast By Material Type, 2020-2030
    • 8.3.1. Polymers
        • 8.3.1.1.1. Natural
        • 8.3.1.1.1.1. Hyaluronic Acid
        • 8.3.1.1.1.2. Chitosan
        • 8.3.1.1.1.3. Hydroxyapatite
        • 8.3.1.1.1.4. Others
        • 8.3.1.1.2. Synthetic
        • 8.3.1.1.2.1. Polymethylmetacrylate (PMMA)
        • 8.3.1.1.2.2. Polyurethane
        • 8.3.1.1.2.3. Polyester
        • 8.3.1.1.2.4. Polytetrafluoroethylene
        • 8.3.1.1.2.5. Silicone
        • 8.3.1.1.2.6. Polyethylenterephthalate
        • 8.3.1.1.2.7. Others
    • 8.3.2. Metal
    • 8.3.3. Ceramic
    • 8.3.4. Composites
  • 8.4. Market Attractiveness Analysis By Material Type

9. Global Biocompatible Materials Market Analysis 2015-2019 and Forecast 2020-2030, by Application

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Biocompatible Materials Market (US$ Mn) Analysis By Application, 2015-2019
  • 9.3. Current and Future Biocompatible Materials Market (US$ Mn) Analysis and Forecast By Application, 2020-2030
    • 9.3.1. Surgical & medical instruments
        • 9.3.1.1.1. Brain surgery
        • 9.3.1.1.2. Cosmetic and plastic surgery
        • 9.3.1.1.3. Vascular surgery
        • 9.3.1.1.4. Cardiovascular surgery
        • 9.3.1.1.5. Others
    • 9.3.2. Implants
        • 9.3.2.1.1. Orthopedic
        • 9.3.2.1.2. Cardiac
        • 9.3.2.1.3. Dental
    • 9.3.3. Drug delivery
    • 9.3.4. Others
  • 9.4. Market Attractiveness Analysis By Application

10. Global Biocompatible Materials Market Analysis 2015-2019 and Forecast 2020-2030, by End User

  • 10.1. Introduction
  • 10.2. Historical Biocompatible Materials Market (US$ Mn) Analysis By End User, 2015 - 2019
  • 10.3. Current Biocompatible Materials Market (US$ Mn) Analysis and Forecast By End User, 2020 - 2030
    • 10.3.1. Medical device manufacturers
    • 10.3.2. Academic and research institutes
    • 10.3.3. Biopharmaceutical & Pharmaceutical companies
  • 10.4. Market Attractiveness Analysis By End User

11. Global Biocompatible Materials Market Analysis 2015-2019 and Forecast 2020-2030, by Region

  • 11.1. Introduction
  • 11.2. Historical Biocompatible Materials Market (US$ Mn) Analysis By Region, 2015 - 2019
  • 11.3. Current Biocompatible Materials Market (US$ Mn) Analysis and Forecast By Region, 2020 - 2030
    • 11.3.1. North America
    • 11.3.2. Latin America
    • 11.3.3. Europe
    • 11.3.4. East Asia
    • 11.3.5. South Asia
    • 11.3.6. Oceania
    • 11.3.7. Middle East and Africa (MEA)

Market Attractiveness Analysis By Region

12. North America Biocompatible Materials Market Analysis 2015-2019 and Forecast 2020-2030

  • 12.1. Introduction
  • 12.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019
  • 12.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2020-2030
    • 12.3.1. By Country
      • 12.3.1.1. U.S.
      • 12.3.1.2. Canada
    • 12.3.2. By Material Type
    • 12.3.3. By Application
    • 12.3.4. By End User
  • 12.4. Market Attractiveness Analysis
  • 12.5. Key Market Participants - Intensity Mapping

13. Latin America Biocompatible Materials Market Analysis 2015-2019 and Forecast 2020-2030

  • 13.1. Introduction
  • 13.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015 - 2019
  • 13.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2020-2030
    • 13.3.1. By Country
      • 13.3.1.1. Brazil
      • 13.3.1.2. Mexico
      • 13.3.1.3. Argentina
      • 13.3.1.4. Rest of Latin America
    • 13.3.2. By Material Type
    • 13.3.3. By Application
    • 13.3.4. By End User
  • 13.4. Market Attractiveness Analysis
  • 13.5. Key Market Participants - Intensity Mapping

14. Europe Biocompatible Materials Market Analysis 2015-2019 and Forecast 2020-2030

  • 14.1. Introduction
  • 14.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019
  • 14.3. Market Value (US$ Mn) Forecast By Market Taxonomy2020-2030
    • 14.3.1. By Country
      • 14.3.1.1. Germany
      • 14.3.1.2. Italy
      • 14.3.1.3. France
      • 14.3.1.4. U.K.
      • 14.3.1.5. Spain
      • 14.3.1.6. BENELUX
      • 14.3.1.7. Russia
      • 14.3.1.8. Rest of Europe
    • 14.3.2. By Material Type
    • 14.3.3. By Application
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
  • 14.5. Key Market Participants - Intensity Mapping

15. South Asia Biocompatible Materials Market Analysis 2015-2019 and Forecast 2020-2030

  • 15.1. Introduction
  • 15.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019
  • 15.3. Market Value (US$ Mn) Forecast By Market Taxonomy2020-2030
    • 15.3.1. By Country
      • 15.3.1.1. India
      • 15.3.1.2. Thailand
      • 15.3.1.3. Indonesia
      • 15.3.1.4. Malaysia
      • 15.3.1.5. Rest of South Asia
    • 15.3.2. By Material Type
    • 15.3.3. By Application
    • 15.3.4. By End User
  • 15.4. Market Attractiveness Analysis
  • 15.5. Key Market Participants - Intensity Mapping

16. East Asia Biocompatible Materials Market Analysis 2015-2019 and Forecast 2020-2030

  • 16.1. Introduction
  • 16.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019
  • 16.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2020-2030
    • 16.3.1. By Country
      • 16.3.1.1. China
      • 16.3.1.2. Japan
      • 16.3.1.3. South Korea
    • 16.3.2. By Material Type
    • 16.3.3. By Application
    • 16.3.4. By End User
  • 16.4. Market Attractiveness Analysis
  • 16.5. Key Market Participants - Intensity Mapping

17. Oceania Biocompatible Materials Market Analysis 2015-2019 and Forecast 2020-2030

  • 17.1. Introduction
  • 17.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019
  • 17.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2020-2030
    • 17.3.1. By Country
      • 17.3.1.1. Australia
      • 17.3.1.2. New Zealand
    • 17.3.2. By Material Type
    • 17.3.3. By Application
    • 17.3.4. By End User
  • 17.4. Market Attractiveness Analysis
  • 17.5. Key Market Participants - Intensity Mapping

18. Middle East and Africa Biocompatible Materials Market Analysis 2015-2019 and Forecast 2020-2030

  • 18.1. Introduction
  • 18.2. Historical Market Value (US$ Mn) Trend Analysis By Value Taxonomy, 2015-2019
  • 18.3. Market Material (US$ Mn) Forecast By Market Taxonomy, 2020-2030
    • 18.3.1. By Country
      • 18.3.1.1. GCC Countries
      • 18.3.1.2. Turkey
      • 18.3.1.3. South Africa
      • 18.3.1.4. Rest of Middle East and Africa
    • 18.3.2. By Material Type
    • 18.3.3. By Application
    • 18.3.4. By End User
  • 18.4. Market Attractiveness Analysis
  • 18.5. Key Market Participants - Intensity Mapping

19. Key & Emerging Countries Biocompatible Materials Market Analysis 2015-2019 and Forecast 2020-2030

  • 19.1. U.S. Biocompatible Materials Market Analysis
    • 19.1.1. By Material Type
    • 19.1.2. By Application
    • 19.1.3. By End User
  • 19.2. Canada Biocompatible Materials Market Analysis
    • 19.2.1. By Material Type
    • 19.2.2. By Application
    • 19.2.3. By End User
  • 19.3. Brazil Biocompatible Materials Market Analysis
    • 19.3.1. By Material Type
    • 19.3.2. By Application
    • 19.3.3. By End User
  • 19.4. Argentina Biocompatible Materials Market Analysis
    • 19.4.1. By Material Type
    • 19.4.2. By Application
    • 19.4.3. By End User
  • 19.5. Mexico Biocompatible Materials Market Analysis
    • 19.5.1. By Material Type
    • 19.5.2. By Application
    • 19.5.3. By End User
  • 19.6. U.K. Biocompatible Materials Market Analysis
    • 19.6.1. By Material Type
    • 19.6.2. By Application
    • 19.6.3. By End User
  • 19.7. Germany Biocompatible Materials Market Analysis
    • 19.7.1. By Material Type
    • 19.7.2. By Application
    • 19.7.3. By End User
  • 19.8. France Biocompatible Materials Market Analysis
    • 19.8.1. By Material Type
    • 19.8.2. By Application
    • 19.8.3. By End User
  • 19.9. Italy Biocompatible Materials Market Analysis
    • 19.9.1. By Material Type
    • 19.9.2. By Application
    • 19.9.3. By End User
  • 19.10. Spain Biocompatible Materials Market Analysis
    • 19.10.1. By Material Type
    • 19.10.2. By Application
    • 19.10.3. By End User
  • 19.11. Russia Biocompatible Materials Market Analysis
    • 19.11.1. By Material Type
    • 19.11.2. By Application
    • 19.11.3. By End User
  • 19.12. India Biocompatible Materials Market Analysis
    • 19.12.1. By Material Type
    • 19.12.2. By Application
    • 19.12.3. By End User
  • 19.13. Malaysia Biocompatible Materials Market Analysis
    • 19.13.1. By Material Type
    • 19.13.2. By Application
    • 19.13.3. By End User
  • 19.14. Thailand Biocompatible Materials Market Analysis
    • 19.14.1. By Material Type
    • 19.14.2. By Application
    • 19.14.3. By End User
  • 19.15. Indonesia Biocompatible Materials Market Analysis
    • 19.15.1. By Material Type
    • 19.15.2. By Application
    • 19.15.3. By End User
  • 19.16. China Biocompatible Materials Market Analysis
    • 19.16.1. By Material Type
    • 19.16.2. By Application
    • 19.16.3. By End User
  • 19.17. Japan Biocompatible Materials Market Analysis
    • 19.17.1. By Material Type
    • 19.17.2. By Application
    • 19.17.3. By End User
  • 19.18. South Korea Biocompatible Materials Market Analysis
    • 19.18.1. By Material Type
    • 19.18.2. By Application
    • 19.18.3. By End User
  • 19.19. Australia Biocompatible Materials Market Analysis
    • 19.19.1. By Material Type
    • 19.19.2. By Application
    • 19.19.3. By End User
  • 19.20. New Zealand Biocompatible Materials Market Analysis
    • 19.20.1. By Material Type
    • 19.20.2. By Application
    • 19.20.3. By End User
  • 19.21. GCC Countries Biocompatible Materials Market Analysis
    • 19.21.1. By Material Type
    • 19.21.2. By Application
    • 19.21.3. By End User
  • 19.22. South Africa Biocompatible Materials Market Analysis
    • 19.22.1. By Material Type
    • 19.22.2. By Application
    • 19.22.3. By End User

20. Market Structure Analysis

  • 20.1. Market Analysis by Tier of Companies
  • 20.2. Market Concentration
  • 20.3. Market Share Analysis of Top Players
  • 20.4. Market Presence Analysis
    • 20.4.1. Regional footprint of Players
    • 20.4.2. Channel Foot Print by Players

21. Competition Analysis

  • 21.1. Competition Dashboard
  • 21.2. Competition Benchmarking
  • 21.3. Competition Deep Dive
    • 21.3.1. Dupont
      • 21.3.1.1. Overview
      • 21.3.1.2. Kit Portfolio
      • 21.3.1.3. Profitability by Market Segments (Drug/Channel/Region)
      • 21.3.1.4. Sales Footprint
      • 21.3.1.5. Strategy Overview
        • 21.3.1.5.1. Marketing Strategy
        • 21.3.1.5.2. Drug Strategy
        • 21.3.1.5.3. Channel Strategy
    • 21.3.2. Ensinger
      • 21.3.2.1. Overview
      • 21.3.2.2. Kit Portfolio
      • 21.3.2.3. Profitability by Market Segments (Drug/Channel/Region)
      • 21.3.2.4. Sales Footprint
      • 21.3.2.5. Strategy Overview
        • 21.3.2.5.1. Marketing Strategy
        • 21.3.2.5.2. Drug Strategy
        • 21.3.2.5.3. Channel Strategy
    • 21.3.3. Stratasys Ltd.
      • 21.3.3.1. Overview
      • 21.3.3.2. Kit Portfolio
      • 21.3.3.3. Profitability by Market Segments (Drug/Channel/Region)
      • 21.3.3.4. Sales Footprint
      • 21.3.3.5. Strategy Overview
        • 21.3.3.5.1. Marketing Strategy
        • 21.3.3.5.2. Drug Strategy
        • 21.3.3.5.3. Channel Strategy
    • 21.3.4. Covestro AG
      • 21.3.4.1. Overview
      • 21.3.4.2. Kit Portfolio
      • 21.3.4.3. Profitability by Market Segments (Drug/Channel/Region)
      • 21.3.4.4. Sales Footprint
      • 21.3.4.5. Strategy Overview
        • 21.3.4.5.1. Marketing Strategy
        • 21.3.4.5.2. Drug Strategy
        • 21.3.4.5.3. Channel Strategy
    • 21.3.5. Foster Corporation
      • 21.3.5.1. Overview
      • 21.3.5.2. Kit Portfolio
      • 21.3.5.3. Profitability by Market Segments (Drug/Channel/Region)
      • 21.3.5.4. Sales Footprint
      • 21.3.5.5. Strategy Overview
        • 21.3.5.5.1. Marketing Strategy
        • 21.3.5.5.2. Drug Strategy
        • 21.3.5.5.3. Channel Strategy
    • 21.3.6. Merck KGaA
      • 21.3.6.1. Overview
      • 21.3.6.2. Kit Portfolio
      • 21.3.6.3. Profitability by Market Segments (Drug/Channel/Region)
      • 21.3.6.4. Sales Footprint
      • 21.3.6.5. Strategy Overview
        • 21.3.6.5.1. Marketing Strategy
        • 21.3.6.5.2. Drug Strategy
        • 21.3.6.5.3. Channel Strategy
    • 21.3.7. BASF SE (Exxon Mobil Corporation)
      • 21.3.7.1. Overview
      • 21.3.7.2. Kit Portfolio
      • 21.3.7.3. Profitability by Market Segments (Drug/Channel/Region)
      • 21.3.7.4. Sales Footprint
      • 21.3.7.5. Strategy Overview
        • 21.3.7.5.1. Marketing Strategy
        • 21.3.7.5.2. Drug Strategy
        • 21.3.7.5.3. Channel Strategy
    • 21.3.8. Wacker Chemie AG
      • 21.3.8.1. Overview
      • 21.3.8.2. Kit Portfolio
      • 21.3.8.3. Profitability by Market Segments (Drug/Channel/Region)
      • 21.3.8.4. Sales Footprint
      • 21.3.8.5. Strategy Overview
        • 21.3.8.5.1. Marketing Strategy
        • 21.3.8.5.2. Drug Strategy
        • 21.3.8.5.3. Channel Strategy
    • 21.3.9. Celanese Corporation
      • 21.3.9.1. Overview
      • 21.3.9.2. Kit Portfolio
      • 21.3.9.3. Profitability by Market Segments (Drug/Channel/Region)
      • 21.3.9.4. Sales Footprint
      • 21.3.9.5. Strategy Overview
        • 21.3.9.5.1. Marketing Strategy
        • 21.3.9.5.2. Drug Strategy
        • 21.3.9.5.3. Channel Strategy
    • 21.3.10. Royal DSM
      • 21.3.10.1. Overview
      • 21.3.10.2. Kit Portfolio
      • 21.3.10.3. Profitability by Market Segments (Drug/Channel/Region)
      • 21.3.10.4. Sales Footprint
      • 21.3.10.5. Strategy Overview
        • 21.3.10.5.1. Marketing Strategy
        • 21.3.10.5.2. Drug Strategy
        • 21.3.10.5.3. Channel Strategy
    • 21.3.11. Evonik Industries AG
      • 21.3.11.1. Overview
      • 21.3.11.2. Kit Portfolio
      • 21.3.11.3. Profitability by Market Segments (Drug/Channel/Region)
      • 21.3.11.4. Sales Footprint
      • 21.3.11.5. Strategy Overview
        • 21.3.11.5.1. Marketing Strategy
        • 21.3.11.5.2. Drug Strategy
        • 21.3.11.5.3. Channel Strategy
    • 21.3.12. Shin-Etsu Chemical Co. Ltd.
      • 21.3.12.1. Overview
      • 21.3.12.2. Kit Portfolio
      • 21.3.12.3. Profitability by Market Segments (Drug/Channel/Region)
      • 21.3.12.4. Sales Footprint
      • 21.3.12.5. Strategy Overview
        • 21.3.12.5.1. Marketing Strategy
        • 21.3.12.5.2. Drug Strategy
        • 21.3.12.5.3. Channel Strategy
    • 21.3.13. Henkel AG & Co.
      • 21.3.13.1. Overview
      • 21.3.13.2. Kit Portfolio
      • 21.3.13.3. Profitability by Market Segments (Drug/Channel/Region)
      • 21.3.13.4. Sales Footprint
      • 21.3.13.5. Strategy Overview
        • 21.3.13.5.1. Marketing Strategy
        • 21.3.13.5.2. Drug Strategy
        • 21.3.13.5.3. Channel Strategy

22. Assumptions and Acronyms Used

23. Research Methodology

List of Tables

  • Table 01: Global Biocompatible Materials Market Size (US$ Bn) Analysis 2015-2019 and Forecast 2020-2030, By Material Type
  • Table 02: Global Biocompatible Materials Market Size (US$ Bn) Analysis 2015-2019 and Forecast 2020-2030, By Application
  • Table 03: Global Biocompatible Materials Market Size (US$ Bn) Analysis 2015-2019 and Forecast 2020-2030, By End User
  • Table 04: Global Biocompatible Materials Market Size (US$ Bn) Analysis 2015-2019 and Forecast 2020-2030, By Region
  • Table 05: North America Biocompatible Materials Market Size (US$ Bn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 06: North America Biocompatible Materials Market Size (US$ Bn) Analysis 2015-2019 and Forecast 2020-2030, By Material Type
  • Table 07: North America Biocompatible Materials Market Size (US$ Bn) Analysis 2015-2019 and Forecast 2020-2030, By Application
  • Table 08: North America Biocompatible Materials Market Size (US$ Bn) Analysis 2015-2019 and Forecast 2020-2030, By End User
  • Table 09: Latin America Biocompatible Materials Market Size (US$ Bn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 10: Latin America Biocompatible Materials Market Size (US$ Bn) Analysis 2015-2019 and Forecast 2020-2030, By Material Type
  • Table 11: Latin America Biocompatible Materials Market Size (US$ Bn) Analysis 2015-2019 and Forecast 2020-2030, By Application
  • Table 12: Latin America Biocompatible Materials Market Size (US$ Bn) Analysis 2015-2019 and Forecast 2020-2030, By End User
  • Table 13: Europe Biocompatible Materials Market Size (US$ Bn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 14: Europe Biocompatible Materials Market Size (US$ Bn) Analysis 2015-2019 and Forecast 2020-2030, By Material Type
  • Table 15: Europe Biocompatible Materials Market Size (US$ Bn) Analysis 2015-2019 and Forecast 2020-2030, By Application
  • Table 16: Europe Biocompatible Materials Market Size (US$ Bn) Analysis 2015-2019 and Forecast 2020-2030, By End User
  • Table 17: South Asia Biocompatible Materials Market Size (US$ Bn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 18: South Asia Biocompatible Materials Market Size (US$ Bn) Analysis 2015-2019 and Forecast 2020-2030, By Material Type
  • Table 19: South Asia Biocompatible Materials Market Size (US$ Bn) Analysis 2015-2019 and Forecast 2020-2030, By Application
  • Table 20: South Asia Biocompatible Materials Market Size (US$ Bn) Analysis 2015-2019 and Forecast 2020-2030, By End User
  • Table 21: East Asia Biocompatible Materials Market Size (US$ Bn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 22: East Asia Biocompatible Materials Market Size (US$ Bn) Analysis 2015-2019 and Forecast 2020-2030, By Material Type
  • Table 23: East Asia Biocompatible Materials Market Size (US$ Bn) Analysis 2015-2019 and Forecast 2020-2030, By Application
  • Table 24: East Asia Biocompatible Materials Market Size (US$ Bn) Analysis 2015-2019 and Forecast 2020-2030, By End User
  • Table 25: Oceania Biocompatible Materials Market Size (US$ Bn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 26: Oceania Biocompatible Materials Market Size (US$ Bn) Analysis 2015-2019 and Forecast 2020-2030, By Material Type
  • Table 27: Oceania Biocompatible Materials Market Size (US$ Bn) Analysis 2015-2019 and Forecast 2020-2030, By Application
  • Table 28: Oceania Biocompatible Materials Market Size (US$ Bn) Analysis 2015-2019 and Forecast 2020-2030, By End User
  • Table 29: Middle East & Africa Biocompatible Materials Market Size (US$ Bn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 30: Middle East & Africa Biocompatible Materials Market Size (US$ Bn) Analysis 2015-2019 and Forecast 2020-2030, By Material Type
  • Table 31: Middle East & Africa Biocompatible Materials Market Size (US$ Bn) Analysis 2015-2019 and Forecast 2020-2030, By Application
  • Table 32: Middle East & Africa Biocompatible Materials Market Size (US$ Bn) Analysis 2015-2019 and Forecast 2020-2030, By End User

List of Figures

  • Figure 01: Global Biocompatible Materials Market Share Analysis (%), By Material Type, 2020 & 2030
  • Figure 02: Global Biocompatible Materials Market Y-o-Y Analysis (%), By Material Type, 2020-2030
  • Figure 03: Global Biocompatible Materials Market Attractiveness Analysis By Material Type, 2020-2030
  • Figure 04: Global Biocompatible Materials Market Share Analysis (%), By Application, 2020 & 2030
  • Figure 05: Global Biocompatible Materials Market Y-o-Y Analysis (%), By Application, 2020-2030
  • Figure 06: Global Biocompatible Materials Market Attractiveness Analysis By Application, 2020-2030
  • Figure 07: Global Biocompatible Materials Market Share Analysis (%), By End User, 2020 & 2030
  • Figure 08: Global Biocompatible Materials Market Y-o-Y Analysis (%), By End User, 2020-2030
  • Figure 09: Global Biocompatible Materials Market Attractiveness Analysis By End User, 2020-2030
  • Figure 10: Global Biocompatible Materials Market Share Analysis (%), By Region Type, 2020 & 2030
  • Figure 11: Global Biocompatible Materials Market Y-o-Y Analysis (%), By Region Type, 2020-2030
  • Figure 12: Global Biocompatible Materials Market Attractiveness Analysis By Region, 2020-2030
  • Figure 13: North America Biocompatible Materials Market Split By Country 2020 (E)
  • Figure 14: North America Biocompatible Materials Market Split By Application 2020 (E)
  • Figure 15: North America Biocompatible Materials Market Split By Material Type 2020 (E)
  • Figure 16: North America Biocompatible Materials Market Split By End User 2020 (E)
  • Figure 17: North America Biocompatible Materials Market Value Analysis (US$ Bn), 2015-2019
  • Figure 18: North America Biocompatible Materials Market Value Forecast (US$ Bn), 2020-2030
  • Figure 19: North America Biocompatible Materials Market Attractiveness Analysis, By Material
  • Figure 20: North America Biocompatible Materials Market Attractiveness Analysis, By Application
  • Figure 21: North America Biocompatible Materials Market Attractiveness Analysis By End User, 2020-2030
  • Figure 22: North America Biocompatible Materials Market Attractiveness Analysis By Country, 2020-2030
  • Figure 23: Latin America Biocompatible Materials Market Split By Country 2020 (E)
  • Figure 24: Latin America Biocompatible Materials Market Split By Application 2020 (E)
  • Figure 25: Latin America Biocompatible Materials Market Split By Material Type 2020 (E)
  • Figure 26: Latin America Biocompatible Materials Market Split By End User 2020 (E)
  • Figure 27: Latin America Biocompatible Materials Market Value Analysis (US$ Bn), 2015-2019
  • Figure 28:Latin America Biocompatible Materials Market Value Forecast (US$ Bn), 2020-2030
  • Figure 29: Latin America Biocompatible Materials Market Attractiveness Analysis, By Material Type
  • Figure 30: Latin America Biocompatible Materials Market Attractiveness Analysis, By Application
  • Figure 31: Latin America Biocompatible Materials Market Attractiveness Analysis By End User, 2020-2030
  • Figure 32: Latin America Biocompatible Materials Market Attractiveness Analysis By Country, 2020-2030
  • Figure 33: Europe Biocompatible Materials Market Split By Country 2020 (E)
  • Figure 34: Europe Biocompatible Materials Market Split By Application 2020 (E)
  • Figure 35: Europe Biocompatible Materials Market Split By Material Type 2020 (E)
  • Figure 36: Europe Biocompatible Materials Market Split By End User 2020 (E)
  • Figure 37: Europe Biocompatible Materials Market Value Analysis (US$ Bn), 2015-2019
  • Figure 38: Europe Biocompatible Materials Market Value Forecast (US$ Bn), 2020-2030
  • Figure 39: Europe Biocompatible Materials Market Attractiveness Analysis, By Material Type
  • Figure 40: Europe Biocompatible Materials Market Attractiveness Analysis, By Application
  • Figure 41: Europe Biocompatible Materials Market Attractiveness Analysis By End User, 2020-2030
  • Figure 42: Europe Biocompatible Materials Market Attractiveness Analysis By Country, 2020-2030
  • Figure 43: South Asia Biocompatible Materials Market Split By Country 2020 (E)
  • Figure 44: South Asia Biocompatible Materials Market Split By Application 2020 (E)
  • Figure 45: South Asia Biocompatible Materials Market Split By Material Type 2020 (E)
  • Figure 46: South Asia Biocompatible Materials Market Split By End User 2020 (E)
  • Figure 47: South Asia Biocompatible Materials Market Value Analysis (US$ Bn), 2015-2019
  • Figure 48: South Asia Biocompatible Materials Market Value Forecast (US$ Bn), 2020-2030
  • Figure 49: South Asia Biocompatible Materials Market Attractiveness Analysis, By Material Type
  • Figure 50: South Asia Biocompatible Materials Market Attractiveness Analysis, By Application
  • Figure 51: South Asia Biocompatible Materials Market Attractiveness Analysis By End User, 2020-2030
  • Figure 52: South Asia Biocompatible Materials Market Attractiveness Analysis By Country, 2020-2030
  • Figure 53: East Asia Biocompatible Materials Market Split By Country 2020 (E)
  • Figure 54: East Asia Biocompatible Materials Market Split By Application 2020 (E)
  • Figure 55: East Asia Biocompatible Materials Market Split By Material Type 2020 (E)
  • Figure 56: East Asia Biocompatible Materials Market Split By End User 2020 (E)
  • Figure 57: East Asia Biocompatible Materials Market Value Analysis (US$ Bn), 2015-2019
  • Figure 58: East Asia Biocompatible Materials Market Value Forecast (US$ Bn), 2020-2030
  • Figure 59: East Asia Biocompatible Materials Market Attractiveness Analysis, By Material Type
  • Figure 60: East Asia Biocompatible Materials Market Attractiveness Analysis, By Application
  • Figure 61: East Asia Biocompatible Materials Market Attractiveness Analysis By End User, 2020-2030
  • Figure 62: East Asia Biocompatible Materials Market Attractiveness Analysis By Country, 2020-2030
  • Figure 63: Oceania Biocompatible Materials Market Split By Country 2020 (E)
  • Figure 64: Oceania Biocompatible Materials Market Split By Application 2020 (E)
  • Figure 65: Oceania Biocompatible Materials Market Split By Material Type 2020 (E)
  • Figure 66: Oceania Biocompatible Materials Market Split By End User 2020 (E)
  • Figure 67: Oceania Biocompatible Materials Market Value Analysis (US$ Bn), 2015-2019
  • Figure 68: Oceania Biocompatible Materials Market Value Forecast (US$ Bn), 2020-2030
  • Figure 69: Oceania Biocompatible Materials Market Attractiveness Analysis, By Material Type
  • Figure 70: Oceania Biocompatible Materials Market Attractiveness Analysis, By Application
  • Figure 71: Oceania Biocompatible Materials Market Attractiveness Analysis By End User, 2020-2030
  • Figure 72: Oceania Biocompatible Materials Market Attractiveness Analysis By Country, 2020-2030
  • Figure 73: Middle East and Africa Biocompatible Materials Market Split By Country 2020 (E)
  • Figure 74: Middle East and Africa Biocompatible Materials Market Split By Application 2020 (E)
  • Figure 75: Middle East and Africa Biocompatible Materials Market Split By Material Type 2020 (E)
  • Figure 76: Middle East and Africa Biocompatible Materials Market Split By End User 2020 (E)
  • Figure 77: Middle East and Africa Biocompatible Materials Market Value Analysis (US$ Bn), 2015-2019
  • Figure 78: Middle East and Africa Biocompatible Materials Market Value Forecast (US$ Bn), 2020-2030
  • Figure 79: Middle East & Africa Biocompatible Materials Market Attractiveness Analysis, By Material Type
  • Figure 80: Middle East & Africa Biocompatible Materials Market Attractiveness Analysis, By Application
  • Figure 81: Middle East & Africa Biocompatible Materials Market Attractiveness Analysis By End User, 2020-2030
  • Figure 82: Middle East & Africa Biocompatible Materials Market Attractiveness Analysis By Country, 2020-2030
  • Figure 83: U.S. Biocompatible Materials Share Analysis (%) By Material Type, 2020 & 2030
  • Figure 84: U.S. Biocompatible Materials Share Analysis (%) By End User, 2020 & 2030
  • Figure 85: U.S. Biocompatible Materials Share Analysis (%) By Application, 2020 & 2030
  • Figure 86: U.S Biocompatible Materials Value Proportion Analysis, By 2020E
  • Figure 87: Canada . Biocompatible Materials Share Analysis (%) By Material Type, 2020 & 2030
  • Figure 88: Canada . Biocompatible Materials Share Analysis (%) By End User, 2020 & 2030
  • Figure 89: Canada . Biocompatible Materials Share Analysis (%) By Application, 2020 & 2030
  • Figure 90: Canada Biocompatible Materials Value Proportion Analysis, By 2020E
  • Figure 91: Brazil Biocompatible Materials Share Analysis (%) By Material Type, 2020 & 2030
  • Figure 92: Brazil Biocompatible Materials Share Analysis (%) By End User, 2020 & 2030
  • Figure 93: Brazil Biocompatible Materials Share Analysis (%) By Application, 2020 & 2030
  • Figure 94: Brazil Biocompatible Materials Value Proportion Analysis, By 2020E
  • Figure 95: Mexico Biocompatible Materials Share Analysis (%) By Material Type, 2020 & 2030
  • Figure 96: Mexico Biocompatible Materials Share Analysis (%) By End User, 2020 & 2030
  • Figure 97: Mexico Biocompatible Materials Share Analysis (%) By Application, 2020 & 2030
  • Figure 98: Mexico Biocompatible Materials Value Proportion Analysis, By 2020E
  • Figure 99: Argentina Biocompatible Materials Share Analysis (%) By Material Type, 2020 & 2030
  • Figure 100: Argentina Biocompatible Materials Share Analysis (%) By End User, 2020 & 2030
  • Figure 101: Argentina Biocompatible Materials Share Analysis (%) By Application, 2020 & 2030
  • Figure 102: Argentina Biocompatible Materials Value Proportion Analysis, By 2020E
  • Figure 103: U.K. Biocompatible Materials Share Analysis (%) By Material Type, 2020 & 2030
  • Figure 104: U.K. Biocompatible Materials Share Analysis (%) By End User, 2020 & 2030
  • Figure 105: U.K. Biocompatible Materials Share Analysis (%) By Application, 2020 & 2030
  • Figure 106: U.K. Biocompatible Materials Value Proportion Analysis, By 2020E
  • Figure 107: Germany Biocompatible Materials Share Analysis (%) By Material Type, 2020 & 2030
  • Figure 108: Germany Biocompatible Materials Share Analysis (%) By End User, 2020 & 2030
  • Figure 109: Germany Biocompatible Materials Share Analysis (%) By Application, 2020 & 2030
  • Figure 110: Germany Biocompatible Materials Value Proportion Analysis, By 2020E
  • Figure 111: France Biocompatible Materials Share Analysis (%) By Material Type, 2020 & 2030
  • Figure 112: France Biocompatible Materials Share Analysis (%) By End User, 2020 & 2030
  • Figure 113: France Biocompatible Materials Share Analysis (%) By Application, 2020 & 2030
  • Figure 114: France Biocompatible Materials Value Proportion Analysis, By 2020E
  • Figure 115: Italy Biocompatible Materials Share Analysis (%) By Material Type, 2020 & 2030
  • Figure 116: Italy Biocompatible Materials Share Analysis (%) By End User, 2020 & 2030
  • Figure 117: Italy Biocompatible Materials Share Analysis (%) By Application, 2020 & 2030
  • Figure 118: Italy Biocompatible Materials Value Proportion Analysis, By 2020E
  • Figure 119: Spain Biocompatible Materials Share Analysis (%) By Material Type, 2020 & 2030
  • Figure 120: Spain Biocompatible Materials Share Analysis (%) By End User, 2020 & 2030
  • Figure 121: Spain Biocompatible Materials Share Analysis (%) By Application, 2020 & 2030
  • Figure 122: Spain Biocompatible Materials Value Proportion Analysis, By 2020E
  • Figure 123: Russia Biocompatible Materials Share Analysis (%) By Material Type, 2020 & 2030
  • Figure 124: Russia Biocompatible Materials Share Analysis (%) By End User, 2020 & 2030
  • Figure 125: Russia Biocompatible Materials Share Analysis (%) By Application, 2020 & 2030
  • Figure 126: Russia Biocompatible Materials Value Proportion Analysis, By 2020E
  • Figure 127: India Biocompatible Materials Share Analysis (%) By Material Type, 2020 & 2030
  • Figure 128: India Biocompatible Materials Share Analysis (%) By End User, 2020 & 2030
  • Figure 129: India Biocompatible Materials Share Analysis (%) By Application, 2020 & 2030
  • Figure 130: India Biocompatible Materials Value Proportion Analysis, By 2020E
  • Figure 131: Malaysia Biocompatible Materials Share Analysis (%) By Material Type, 2020 & 2030
  • Figure 132: Malaysia Biocompatible Materials Share Analysis (%) By End User, 2020 & 2030
  • Figure 133: Malaysia Biocompatible Materials Share Analysis (%) By Application, 2020 & 2030
  • Figure 134: Malaysia Biocompatible Materials Value Proportion Analysis, By 2020E
  • Figure 135: Thailand Biocompatible Materials Share Analysis (%) By Material Type, 2020 & 2030
  • Figure 136: Thailand Biocompatible Materials Share Analysis (%) By End User, 2020 & 2030
  • Figure 137: Thailand Biocompatible Materials Share Analysis (%) By Application, 2020 & 2030
  • Figure 138: Thailand Biocompatible Materials Value Proportion Analysis, By 2020E
  • Figure 139: Indonesia Biocompatible Materials Share Analysis (%) By Material Type, 2020 & 2030
  • Figure 140: Indonesia Biocompatible Materials Share Analysis (%) By End User, 2020 & 2030
  • Figure 141: Indonesia Biocompatible Materials Share Analysis (%) By Application, 2020 & 2030
  • Figure 142: Indonesia Biocompatible Materials Value Proportion Analysis, By 2020E
  • Figure 143: China Biocompatible Materials Share Analysis (%) By Material Type, 2020 & 2030
  • Figure 144: China Biocompatible Materials Share Analysis (%) By End User, 2020 & 2030
  • Figure 145: China Biocompatible Materials Share Analysis (%) By Application, 2020 & 2030
  • Figure 146: China Biocompatible Materials Value Proportion Analysis, By 2020E
  • Figure 147: Japan Biocompatible Materials Share Analysis (%) By Material Type, 2020 & 2030
  • Figure 148: Japan Biocompatible Materials Share Analysis (%) By End User, 2020 & 2030
  • Figure 149: Japan Biocompatible Materials Share Analysis (%) By Application, 2020 & 2030
  • Figure 150: Japan Biocompatible Materials Value Proportion Analysis, By 2020E
  • Figure 151: South Korea Biocompatible Materials Share Analysis (%) By Material Type, 2020 & 2030
  • Figure 152: South Korea Biocompatible Materials Share Analysis (%) By End User, 2020 & 2030
  • Figure 153: South Korea Biocompatible Materials Share Analysis (%) By Application, 2020 & 2030
  • Figure 154: South Korea Biocompatible Materials Value Proportion Analysis, By 2020E
  • Figure 155: Australia Biocompatible Materials Share Analysis (%) By Material Type, 2020 & 2030
  • Figure 156: Australia Biocompatible Materials Share Analysis (%) By End User, 2020 & 2030
  • Figure 157: Australia Biocompatible Materials Share Analysis (%) By Application, 2020 & 2030
  • Figure 158: Australia Biocompatible Materials Value Proportion Analysis, By 2020E
  • Figure 159: New Zealand Biocompatible Materials Share Analysis (%) By Material Type, 2020 & 2030
  • Figure 160: New Zealand Biocompatible Materials Share Analysis (%) By End User, 2020 & 2030
  • Figure 161: New Zealand Biocompatible Materials Share Analysis (%) By Application, 2020 & 2030
  • Figure 162: New Zealand Biocompatible Materials Value Proportion Analysis, By 2020E
  • Figure 163: GCC Countries Biocompatible Materials Share Analysis (%) By Material Type, 2020 & 2030
  • Figure 164: GCC Countries Biocompatible Materials Share Analysis (%) By End User, 2020 & 2030
  • Figure 165: GCC Countries Biocompatible Materials Share Analysis (%) By Application, 2020 & 2030
  • Figure 166: GCC Countries Biocompatible Materials Value Proportion Analysis, By 2020E
  • Figure 167: South Africa Biocompatible Materials Share Analysis (%) By Material Type, 2020 & 2030
  • Figure 168: South Africa Biocompatible Materials Share Analysis (%) By End User, 2020 & 2030
  • Figure 169: South Africa Biocompatible Materials Share Analysis (%) By Application, 2020 & 2030